Cargando…
New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology
Nicotinamide phosphoribosyltransferase (NAMPT) is crucial for nicotinamide adenine dinucleotide (NAD(+)) biosynthesis in mammalian cells. NAMPT inhibitors represent multifunctional anticancer agents that act on NAD(+) metabolism to shut down glycolysis, nucleotide biosynthesis, and ATP generation an...
Autores principales: | Roulston, Anne, Shore, Gordon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845202/ https://www.ncbi.nlm.nih.gov/pubmed/27308565 http://dx.doi.org/10.1080/23723556.2015.1052180 |
Ejemplares similares
-
Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy
por: Cole, Jonathan, et al.
Publicado: (2017) -
Targeting NAMPT as a therapeutic strategy against stroke
por: Wang, Shu-Na, et al.
Publicado: (2019) -
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
por: Galli, Ubaldina, et al.
Publicado: (2020) -
Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
por: Lin, Tsung-Chieh
Publicado: (2022) -
Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity
por: Lynn, Heather, et al.
Publicado: (2023)